Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations

Nadia Emad Lotfi Amin, Torben Frøstrup Hansen, Eva Fernebro, John Ploen, Jakob Eberhard, Jan Lindebjerg, Lars Henrik Jensen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology